Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis

被引:61
作者
Burska, Agata N. [1 ,2 ]
Hunt, Laura [1 ,2 ]
Boissinot, Marjorie [3 ]
Strollo, Rocky [4 ]
Ryan, Brent J. [5 ]
Vital, Ed [1 ,2 ]
Nissim, Ahuva [4 ]
Winyard, Paul G. [6 ]
Emery, Paul [1 ,2 ]
Ponchel, Frederique [1 ,2 ]
机构
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Dis, Leeds LS9 7TF, W Yorkshire, England
[2] Leeds Trust Teaching Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS9 7TF, W Yorkshire, England
[3] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[4] Univ London, Ctr Biochem Pharmacol Res Unit, Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
[5] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England
[6] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England
关键词
CYCLIC CITRULLINATED PEPTIDE; LOW-DENSITY-LIPOPROTEIN; ANTICITRULLINATED PROTEIN ANTIBODIES; GLYCATION END-PRODUCTS; COLLAGEN TYPE-II; HUMAN EPIDERMIS FILAGGRIN; CHRONIC-RENAL-FAILURE; STRESS MARKER LEVELS; SYNOVIAL-FLUID; OXIDATIVE STRESS;
D O I
10.1155/2014/492873
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Autoantibodies have been associated with human pathologies for a long time, particularly with autoimmune diseases (AIDs). Rheumatoid factor (RF) is known since the late 1930s to be associated with rheumatoid arthritis (RA). The discovery of anticitrullinated protein antibodies in the last century has changed this and other posttranslational modifications (PTM) relevant to RA have since been described. Such PTM introduce neoepitopes in proteins that can generate novel autoantibody specificities. The recent recognition of these novel specificities in RA provides a unique opportunity to understand human B-cell development in vivo. In this paper, we will review the three of the main classes of PTMs already associated with RA: citrullination, carbamylation, and oxidation. With the advancement of research methodologies it should be expected that other autoantibodies against PTM proteins could be discovered in patients with autoimmune diseases. Many of such autoantibodies may provide significant biomarker potential.
引用
收藏
页数:19
相关论文
共 257 条
[1]
Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease [J].
Acharya, Nimish K. ;
Nagele, Eric P. ;
Han, Min ;
Coretti, Nicholas J. ;
DeMarshall, Cassandra ;
Kosciuk, Mary C. ;
Boulos, Paul A. ;
Nagele, Robert G. .
JOURNAL OF AUTOIMMUNITY, 2012, 38 (04) :369-380
[2]
STUDY OF PROCAINAMIDE HAPTEN-SPECIFIC ANTIBODIES IN RABBITS AND HUMANS [J].
ADAMS, LE ;
ROBERTS, SM ;
DONOVANBRAND, R ;
ZIMMER, H ;
HESS, EV .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (08) :887-897
[3]
Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients [J].
Ahmad, Saman ;
Habib, Safia ;
Moinuddin ;
Ali, Asif .
HUMAN IMMUNOLOGY, 2013, 74 (01) :23-27
[4]
Hydroxyl Radical Modification of Immunoglobulin G Generated Cross-Reactive Antibodies: Its Potential Role in Systemic Lupus Erythematosus [J].
Al-Shobaili, Hani A. ;
Al Robaee, Ahmad A. ;
Alzolibani, Abdullateef ;
Khan, Muhammad Ismail ;
Rasheed, Zafar .
CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2011, 4 :11-19
[5]
Psoriatic arthritis - New insights give new options for treatment [J].
Alenius, G. M. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (03) :359-366
[6]
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement [J].
Alessandri, C ;
Bombardieri, M ;
Papa, N ;
Cinquini, M ;
Magrini, L ;
Tincani, A ;
Valesini, G .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1218-1221
[7]
The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis [J].
Alessandri, Cristiano ;
Priori, Roberta ;
Modesti, Mariagrazia ;
Mancini, Riccardo ;
Valesini, Guido .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (01) :45-49
[8]
Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]
[9]
Allanore Y, 2004, CLIN EXP RHEUMATOL, V22, P756
[10]
Amengual O, 1997, BRIT J RHEUMATOL, V36, P964